Post-Reperfusion Myocardial Infarction. Long-Term Survival Improvement Using Adenosine Regulation With Acadesine

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 206-214

  Mangano, Dennis T ^a   Miao, Yinghui ^a   Tudor, Iulia C ^a   Dietzel, Cynthia ^a  

^a Ischemia Research and Education Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE; CARDIOPLEGIC AGENT; CREATINE KINASE MB; PLACEBO;

ADULT; ARTICLE; AUTOPSY; BLEEDING; CARDIOPLEGIA; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; INFECTION; MALE; MORTALITY; MULTICENTER STUDY; PNEUMONIA; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SURVIVAL;

ADENOSINE; AGED; AMINOIMIDAZOLE CARBOXAMIDE; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PREOPERATIVE CARE; RIBONUCLEOSIDES; RISK FACTORS; SURVIVAL RATE;

EID: 33745230105     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.04.044     Document Type: Article

References (27)

1. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part I. Circulation 104 (2001) 2981-2989
2. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part II. Circulation 104 (2001) 3158-3167
3. Neumann F.J., Blasini R., Schmitt C., et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 98 (1998) 2695-2701
4. Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 (2001) 1895-1903
5. Tcheng J.E., Kandzari D.E., Grines C.L., et al. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction. the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 108 (2003) 1316-1323
6. Mangano D.T. Perioperative cardiac morbidity-epidemiology, costs, problems, and solutions. West J Med 161 (1994) 87-89
7. Mangano D.T., and Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Effects of acadesine on myocardial infarction, stroke, and death following surgery. a meta-analysis of the five international randomized trials. JAMA 277 (1997) 325-332
8. Baran K.W., Nguyen M., McKendall G.R., et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction. limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation 104 (2001) 2778-2783
9. The EMIP-FR Group. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy: a double-blind, placebo-controlled, randomized trial. European myocardial infarction project-free radicals. Eur Heart J 21 (2000) 1537-1546
10. Flaherty J.T., Pitt B., Gruber J.W., et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89 (1994) 1982-1991
11. Faxon D.P., Gibbons R.J., Chronos N.A., et al. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty. the results of the HALT-MI study. J Am Coll Cardiol 40 (2002) 1199-1204
12. Mentzer Jr. R.M., and EXPEDITION Study Investigators. Effects of Na+H+ exchange inhibition by cariporide on death and nonfatal myocardial infarction in patients undergoing coronary artery bypass graft surgery. the EXPEDITION study. Circulation 108 (2003) 3M
13. Zeymer U., Suryapranata H., Monassier J.P., et al. The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38 (2001) 1644-1650
14. Mahaffey K.W., Granger C.B., Nicolau J.C., et al. Effect of pexelizumab, and anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction. the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial. Circulation 108 (2003) 1176-1183
15. Granger C.B., Mahaffey K.W., Weaver W.D., et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction. the complement inhibition in myocardial infarction treated with angioplasty (COMMA) trial. Circulation 108 (2003) 1184-1190
16. Verrier E.D., Shernan S.K., Taylor K.M., et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass. a randomized trial. JAMA 291 (2004) 2319-2327
17. O'Neill WW. Cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction. Presented at: Transcatheter Cardiovascular Therapeutics Meeting; Washington, DC: 2003.
18. Grines CL. Intravascular cooling adjunctive to percutaneous coronary intervention for acute myocardial infarction. Presented at: Transcatheter Cardiovascular Therapeutics Meeting; Washington, DC: September 2004.
19. Dixon S.R., Bartorelli A.L., Marcovitz P.A., et al. Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction. results of a pilot study utilizing intracoronary aqueous oxygen therapy. J Am Coll Cardiol 39 (2002) 387-392
20. O'Neill WW. Acute myocardial infarction with hyperoxemic therapy (AMIHOT): a prospective, randomized, multicenter trial. Presented at: Annual Scientific Session of the American College of Cardiology; New Orleans, LA: March 2004.
21. Stone G.W., Webb J., Cox D.A., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. a randomized controlled trial. JAMA 293 (2005) 1063-1072
22. Gruber H.E., Hoffer M.E., McAllister D.R., et al. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury. Circulation 80 (1989) 1400-1411
23. Engler R.L. Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent. importance of the endothelium. J Card Surg 9 (1994) 482-492
24. Gottlieb R.A., Gruol D.L., Zhu J.Y., and Engler R.L. Preconditioning in rabbit cardiomyocytes. role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 97 (1996) 2391-2398
25. Ross A.M., Gibbons R.J., Stone G.W., et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45 (2005) 1775-1780
26. Mahaffey K.W., Puma J.A., Barbagelata N.A., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD). J Am Coll Cardiol 34 (1999) 1711-1720
27. Marzilli M., Orsini E., Marraccini P., and Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 101 (2000) 2154-2159